Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Pathogenic variants at the N-terminal arginine residue 44 disrupt human GABA transporter 1 function: insights from Drosophila epilepsy models.
Journal: Frontiers in pharmacology
Published: July 28, 2025
A transporter's doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therapeutic prospects.
Journal: Frontiers in molecular neuroscience
Published: July 18, 2024
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
Journal: The New England journal of medicine
Published: February 21, 2019
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 15, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026